CDIX · Cardiff Lexington Corporation
What's happening
- CDIX is down 50.00% today, trading at $0.02. — Live quote
- It's trading within 3% of its 52-week low ($0.02). (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-09-24; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -22.6% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -92.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -90.9%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CDIX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.2M | $3.1M | $2.8M | $2.9M | $1.4M | $1.5M | $2.3M |
| Gross profit | $1.2M | $1.3M | $1.9M | $1.7M | $1.8M | $355.0K | $678.6K | $1.4M |
| Operating income | -$544.6K | -$511.2K | $643.3K | $609.7K | $543.9K | -$585.2K | -$159.5K | $219.0K |
| Net income | -$2.5M | -$3.1M | -$1.1M | -$1.2M | -$450.8K | -$2.0M | -$131.6K | -$283.1K |
| EPS (diluted) | $-0.18 | $-0.23 | — | $-0.24 | $-0.14 | — | — | — |
| EPS (basic) | $-0.18 | $-0.23 | — | $-0.24 | $-0.14 | — | — | — |
| Operating margin | -$25 | -$23 | $21 | $22 | $19 | -$43 | -$11 | $9 |
| Net margin | -$115 | -$139 | -$37 | -$44 | -$15 | -$146 | -$9 | -$12 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Jan '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $30.7M | $30.3M | $29.1M | $27.6M | $26.5M | $25.3M | — | $23.9M |
| Total liabilities | $27.1M | $24.6M | $26.0M | $22.6M | $20.5M | $18.2M | — | $16.3M |
| Stockholders' equity | $1.8M | $3.9M | -$2.5M | -$364.4K | $753.6K | $2.0M | — | $2.7M |
| Total current assets | $24.3M | $23.9M | $22.6M | $21.0M | $19.9M | $18.6M | — | $17.2M |
| Total current liabilities | $26.6M | $24.4M | $25.8M | $22.4M | $20.3M | $17.9M | — | $15.9M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | $23.7M | $22.9M | $22.1M | $20.7M | $19.2M | $17.5M | $15.9M | $15.9M |
| Inventory | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $2.1K | $2.4K | $3.0K | $3.7K | $4.5K | $5.2K | — | $21.2K |
| Goodwill | $5.7M | $5.7M | $5.7M | $5.7M | $5.7M | $5.7M | — | $5.7M |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $1.5M | $1.2M | $1.1M | $846.4K | $722.3K | $709.7K | — | $684.3K |
| Accrued liabilities | — | — | $1.6K | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $22.7M | — | $18.6M | $15.1M | $13.1M | $10.7M | — | $9.2M |
| Common stock & paid-in capital | $15.3K | $15.2K | $13.7K | $19.9K | $19.7K | $15.3K | — | $5.1K |
| Retained earnings | -$85.6M | -$82.9M | -$79.5M | -$76.5M | -$75.1M | -$73.6M | — | -$72.9M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$651.9K | -$16.7K | — | — | -$1.4M | -$491.4K | — | — |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | $186.1K | $381.7K | $476.5K | $246.6K | $960.5K | $300.0K | -$38.9K | -$339.3K |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $253 | $593 | $762 | $762 | $763 | $3.4K | $3.4K | $3.4K |
| Share-based compensation | $366.9K | $664.2K | $754.5K | $41.2K | $97.5K | $0 | $244.5K | $0 |
| Change in accounts receivable | $864.7K | $819.9K | $1.5M | $1.5M | $1.7M | $1.7M | $1.4M | $1.6M |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $50.0K | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $11.5M | $8.3M | $11.9M | $10.7M | $9.9M |
| Gross profit | $7.2M | $4.4M | $8.3M | $6.6M | $6.1M |
| Operating income | $1.1M | -$193.5K | $5.2M | $3.9M | $1.7M |
| Net income | -$5.5M | -$3.3M | $3.0M | -$5.4M | $666.3K |
| EPS (diluted) | — | — | — | — | $-0.01 |
| EPS (basic) | — | — | — | — | $-0.01 |
| Operating margin | $10 | -$2 | $44 | $37 | $17 |
| Net margin | -$48 | -$40 | $26 | -$51 | $7 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Jan '24 | Dec '23 | Jan '23 |
|---|---|---|---|---|---|
| Total assets | $29.1M | $23.9M | — | $20.7M | — |
| Total liabilities | $26.0M | $16.3M | — | $14.1M | — |
| Stockholders' equity | -$2.5M | $2.7M | — | $731.4K | — |
| Total current assets | $22.6M | $17.2M | — | $14.2M | — |
| Total current liabilities | $25.8M | $15.9M | — | $13.9M | — |
| Cash & equivalents | — | — | — | — | — |
| Accounts receivable | $22.1M | $15.9M | $13.3M | $13.3M | $6.6M |
| Inventory | — | — | — | — | — |
| Property, plant & equipment | $3.0K | $21.2K | — | $34.7K | — |
| Goodwill | $5.7M | $5.7M | — | $5.7M | — |
| Intangible assets | — | — | — | — | — |
| Accounts payable | $1.1M | $684.3K | — | $720.8K | — |
| Accrued liabilities | $1.6K | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — |
| Short-term debt | — | — | — | — | — |
| Long-term debt | $18.6M | $9.2M | — | $2.3M | — |
| Common stock & paid-in capital | $13.7K | $5.1K | — | $25 | — |
| Retained earnings | -$79.5M | -$72.9M | — | -$68.7M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | -$1.7M | -$1.2M | — |
| Investing cash flow | — | — | — | $0 | -$2.3M |
| Financing cash flow | $2.0M | $3.0M | $2.4M | $788.8K | $3.7M |
| Free cash flow | — | — | — | -$1.2M | — |
| Capital expenditures | — | — | — | $0 | $3.4K |
| Depreciation & amortization | $5.7K | $13.5K | $20.8K | $23.1K | $13.9K |
| Share-based compensation | $754.5K | $544.7K | $0 | — | — |
| Change in accounts receivable | $6.4M | $4.5M | $6.8M | $597.5K | $2.2M |
| Change in inventory | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — |
| Dividends paid | $50.0K | $100.0K | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CDIX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2013-12-06 to 2026-04-01
Recent transactions
- Most recent: Staley Louis Jack Sr. (Director) — Grant / award of 5,000 shares on 2026-04-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Staley Louis Jack Sr. | Director | Grant / award | 2026-04-01 | 5,000 |
| Pennington Catherine B. | Director | Grant / award | 2026-04-01 | 5,000 |
| Johnson Gillard B. III | Director | Grant / award | 2026-04-01 | 5,000 |
| Cunningham Alex H. | Chief Executive Officer | Other acquisition/disposition | 2026-01-29 | 556,528 |
| Shafer Matthew T | Chief Financial Officer | Grant / award | 2026-01-13 | 62,500 |
| THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 2025-11-19 | 9,192,092 |
| MCCARTHY DAVID LAWRENCE | 10% owner | Open market sale | 2018-10-30 | 15,000,000 |
| Roberton Kathleen | Chief Executive Officer | Grant / award | 2014-10-10 | 1,500,000 |
| Levy Jason A | 10% owner | Grant / award | 2014-10-10 | 1,500,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-04-01 | Staley Louis Jack Sr. | Director | Grant / award | 5,000 | $0.00 |
| 2026-04-01 | Pennington Catherine B. | Director | Grant / award | 5,000 | $0.00 |
| 2026-04-01 | Johnson Gillard B. III | Director | Grant / award | 5,000 | $0.00 |
| 2026-01-29 | Cunningham Alex H. | Chief Executive Officer | Other acquisition/disposition | 556,528 | $0.00 |
| 2026-01-13 | Shafer Matthew T | Chief Financial Officer | Grant / award | 62,500 | $0.00 |
| 2025-12-11 | Shafer Matthew T | Chief Financial Officer | Grant / award | 25,000 | $0.00 |
| 2025-11-19 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 9,192,092 | $0.00 |
| 2025-11-19 | Shafer Matthew T | Chief Financial Officer | Derivative conversion | 10,000 | $0.00 |
| 2025-11-19 | Cunningham Alex H. | Chief Executive Officer | Derivative conversion | 10,073,092 | $0.00 |
| 2025-09-26 | Staley Louis Jack Sr. | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-26 | Staley Louis Jack Sr. | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-26 | Pennington Catherine B. | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-26 | Pennington Catherine B. | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-26 | Johnson Gillard B. III | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-26 | Johnson Gillard B. III | Director | Grant / award | 5,000 | $0.00 |
| 2025-09-08 | Cunningham Alex H. | Chief Executive Officer | Other acquisition/disposition | 2,496,834 | $0.00 |
| 2025-09-08 | Cunningham Alex H. | Chief Executive Officer | Other acquisition/disposition | 2,496,834 | $0.00 |
| 2025-04-24 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 1,050,000 | $0.00 |
| 2025-04-24 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 270,000 | $0.00 |
| 2025-04-24 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 154,000 | $0.00 |
| 2025-04-24 | Cunningham Alex H. | Chief Executive Officer | Derivative conversion | 1,050,000 | $0.00 |
| 2025-04-24 | Cunningham Alex H. | Chief Executive Officer | Derivative conversion | 270,000 | $0.00 |
| 2025-04-24 | Cunningham Alex H. | Chief Executive Officer | Derivative conversion | 154,000 | $0.00 |
| 2024-10-25 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 26,124 | $0.00 |
| 2024-10-25 | THOMPSON DANIEL | Chairman of the Board | Derivative conversion | 10,000 | $0.00 |
| 2024-10-25 | Cunningham Alex H. | President and CEO | Derivative conversion | 12,500 | $2.00 |
| 2024-10-25 | Cunningham Alex H. | President and CEO | Derivative conversion | 10,000 | $10000.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:05 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-24 | 8-K | 2026-09-24 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-08-31 | View on SEC.gov → |
| 2026-08-12 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-05 | View on SEC.gov → |
| 2026-05-13 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-03 | 4 | 2026-04-01 | View on SEC.gov → |
| 2026-04-03 | 4 | 2026-04-01 | View on SEC.gov → |
| 2026-04-03 | 4 | 2026-04-01 | View on SEC.gov → |
| 2026-03-10 | 10-K | 2025-12-31 | View on SEC.gov → |
Recent news
Headlines about CDIX (Cardiff Lexington Corporation). Links open the publisher — we don’t host full articles.
-
Cardiff Lexington signs LOI for up to $104M musculoskeletal healthcare acquisition
Seeking Alpha · 2026-09-24 -
Cardiff Lexington Corporation Announces Letter of Intent for Proposed Acquisition of Leading Musculoskeletal Healthcare Platform
Yahoo Finance · 2026-09-24 -
Cardiff Lexington Corporation 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-17 -
Cardiff Lexington Corp (CDIX) (Q2 2026) Earnings Call Highlights: Revenue Dips Amid Expansion ...
Yahoo Finance · 2026-08-12 -
Cardiff Lexington Corporation (CDIX) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-12 -
Cardiff Lexington H1 Revenue Declines as Working Capital Constraints Pressure Performance
Yahoo Finance · 2026-08-12 -
Cardiff Lexington Announces Second Quarter 2026 Financial Results
Yahoo Finance · 2026-08-12 -
Cardiff Lexington to Report Second Quarter 2026 Financial Results and Host Conference Call on Wednesday, August 12, 2026
Yahoo Finance · 2026-08-06
No headlines in this category right now — try “All”.